MBL and MASP-2 concentrations in serum and MBL2 promoter polymorphisms are associated to schizophrenia

about

MBL and MASP-2 concentrations in serum and MBL2 promoter polymorphisms are associated to schizophrenia

Item

http://www.wikidata.org/entity/Q57516704

description

im August 2012 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2012

@uk

name

MBL and MASP-2 concentrations ...... re associated to schizophrenia

@en

MBL and MASP-2 concentrations ...... re associated to schizophrenia

@nl

type

Item

label

MBL and MASP-2 concentrations ...... re associated to schizophrenia

@en

MBL and MASP-2 concentrations ...... re associated to schizophrenia

@nl

prefLabel

MBL and MASP-2 concentrations ...... re associated to schizophrenia

@en

MBL and MASP-2 concentrations ...... re associated to schizophrenia

@nl

P1476

MBL and MASP-2 concentrations ...... re associated to schizophrenia

@en

P2093

Jens Christian Jensenius

http://www.w3.org/2001/XMLSchema#string

Rudi Steffensen

http://www.w3.org/2001/XMLSchema#string

Thomas Damm Als

http://www.w3.org/2001/XMLSchema#string

P2860

Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering

The mannan-binding lectin pathway of complement activation: biology and disease association

Association of schizophrenia and autoimmune diseases: linkage of Danish national registers

Phylogenetic nomenclature and evolution of mannose-binding lectin (MBL2) haplotypes.

CSMD1 is a novel multiple domain complement-regulatory protein highly expressed in the central nervous system and epithelial tissues.

Mannose-binding lectin in innate immunity: past, present and future.

Are some cases of psychosis caused by microbial agents? A review of the evidence.

Immune system to brain signaling: neuropsychopharmacological implications.

Clinical manifestations of mannan-binding lectin deficiency.

Mannan-binding-lectin-associated serine proteases, characteristics and disease associations.

P304

199-207

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1601-5215.2011.00618.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25286812

http://www.w3.org/2001/XMLSchema#string

P921

schizophrenia